TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+10.4%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.08B
AUM Growth
+$3.08B
(+5.9%)
Cap. Flow
-$52.2M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
31.64%
Holding
198
New
2
Increased
42
Reduced
40
Closed
9
Top Buys
| 1 |
UnitedHealth
UNH
|
$41.4M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$22.5M |
| 3 |
United Therapeutics
UTHR
|
$13.6M |
| 4 |
Thermo Fisher Scientific
TMO
|
$13.4M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$11.7M |
Top Sells
| 1 |
Elevance Health
ELV
|
$21.8M |
| 2 |
Illumina
ILMN
|
$21.3M |
| 3 |
Steris
STE
|
$20.4M |
| 4 |
Waters Corp
WAT
|
$18.8M |
| 5 |
Bristol-Myers Squibb
BMY
|
$15.8M |
Sector Composition
| 1 | Healthcare | 95.67% |
| 2 | Real Estate | 2.94% |
| 3 | Industrials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UnitedHealth
UNH
$281B
| $126M | 4.11% | 315,548 +103,263 | +49% | +$41.4M |
|
2
Amgen
AMGN
$155B
| $113M | 3.67% | 463,405 +46,845 | +11% | +$11.4M |
|
3
Gilead Sciences
GILD
$140B
| $113M | 3.66% | 1,634,785 -181,121 | -10% | -$12.5M |
|
4
Moderna
MRNA
$9.37B
| $109M | 3.56% | 465,777 -6,525 | -1% | -$1.53M |
|
|
5
Illumina
ILMN
$15.8B
| $95.5M | 3.1% | 201,809 -44,984 | -18% | -$21.3M |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $87.7M | 2.85% | 936,340 +125,408 | +15% | +$11.7M |
|
7
Abbott
ABT
$231B
| $87.1M | 2.83% | 750,997 +7,340 | +1% | +$851K |
|
8
Johnson & Johnson
JNJ
$427B
| $85.1M | 2.77% | 516,652 -88,212 | -15% | -$14.5M |
|
9
Vertex Pharmaceuticals
VRTX
$100B
| $79.7M | 2.59% | 395,288 | – | – |
|
10
Regeneron Pharmaceuticals
REGN
$61.5B
| $77.2M | 2.51% | 138,132 -15,373 | -10% | -$8.59M |
|
11
Biogen
BIIB
$19.4B
| $72.4M | 2.35% | 209,124 -37,720 | -15% | -$13.1M |
|
|
12
Thermo Fisher Scientific
TMO
$186B
| $70.7M | 2.3% | 140,130 +26,477 | +23% | +$13.4M |
|
13
AbbVie
ABBV
$372B
| $69.5M | 2.26% | 617,303 -2,456 | -0.4% | -$277K |
|
14
Medtronic
MDT
$119B
| $67.9M | 2.21% | 546,722 +54,508 | +11% | +$6.77M |
|
15
Eli Lilly
LLY
$657B
| $58.9M | 1.91% | 256,561 -35,553 | -12% | -$8.16M |
|
16
Cigna
CI
$80.3B
| $50M | 1.63% | 211,018 +21,097 | +11% | +$5M |
|
17
Danaher
DHR
$147B
| $44.6M | 1.45% | 166,240 -25,000 | -13% | -$6.71M |
|
|
18
Bristol-Myers Squibb
BMY
$96B
| $43.8M | 1.42% | 655,973 -236,480 | -26% | -$15.8M |
|
19
Merck
MRK
$210B
| $42.1M | 1.37% | 541,703 | – | – |
|
|
20
Elevance Health
ELV
$71.8B
| $41.1M | 1.34% | 107,734 -57,043 | -35% | -$21.8M |
|
21
Stryker
SYK
$150B
| $39.1M | 1.27% | 150,500 -1,330 | -0.9% | -$345K |
|
22
Zimmer Biomet
ZBH
$21B
| $35.8M | 1.16% | 222,703 +14,889 | +7% | +$2.39M |
|
23
DexCom
DXCM
$29.5B
| $35.3M | 1.15% | 82,755 +8,112 | +11% | +$3.46M |
|
24
ResMed
RMD
$40.2B
| $34M | 1.1% | 137,807 +5,463 | +4% | +$1.35M |
|
|
SGEN
25
DELISTED
Seagen Inc. Common Stock
SGEN
| $33.3M | 1.08% | 210,759 -14,731 | -7% | -$2.33M |
|